Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Immediately after President Trump revealed that he has been taking hydroxychloroquine as a preventative measure for the coronavirus, Fox News host Neil Cavuto warned viewers that the drug could have deadly consequences for patients with health risks: "It will kill you. I cannot stress enough."

Why it matters: The FDA issued a warning last month that hydroxychloroquine, which has not been proven to prevent coronavirus infections, could cause heart complications in positive COVID-19 patients.

What they’re saying: Cavuto cited multiple studies disproving Trump's claims on the drug's effectiveness in treating the virus, and he rebuked the president's suggestion that there is "nothing to lose."

  • "If you are in a risky population here, and you are taking this as a preventative treatment to ward off the virus, or worst-case scenario you are dealing with the virus, and you are in this vulnerable population, it will kill you. I cannot stress enough, this will kill you."
  • "This is a leap that should not be taken casually by those watching at home, or assuming, well the president of the United States says it's OK. ... I only make this not to make a political point here, but a life-and-death point. Be very, very careful."

What he's saying: Trump retweeted a Twitter user who criticized Cavuto's report with the comment that FoxNews "is no longer the same."

  • "We miss the great Roger Ailes," Trump added, in reference to the network's the former founder, chairman and CEO, who died in 2017. "You have more anti-Trump people, by far, than ever before. Looking for a new outlet!"

Editor's note: This article has been updated with Trump's comments.

Go deeper

Scoop: The Trump-Navarro mind meld on the FDA

Peter Navarro speaks during a briefing on the pandemic, March 27. Photo: Drew Angerer/Getty Images

Senior health officials in the Trump administration were taken aback last Monday when the president's trade adviser, Peter Navarro, accused them of being part of the "Deep State" during a meeting that was supposed to be about COVID-19 and the Strategic National Stockpile.

Why it matters: Five days after Navarro's private comments toward the FDA, the president echoed Navarro's sentiments with a pair of Saturday morning tweets and tagged Stephen Hahn, the head of the Food and Drug Administration.

Updated Aug 23, 2020 - Politics & Policy

FDA announces emergency authorization of plasma treatment for COVID-19

Photo: Anna Moneymaker-Pool/Getty Images

The FDA announced Sunday it will grant an emergency use authorization (EUA) of convalescent plasma as a treatment for the coronavirus, one day after President Trump accused the agency of slow-walking the development of vaccines and therapeutics to hurt him politically.

The state of play: The authorization for plasma, which is safe but not yet proven to work on COVID-19, had been on hold after federal health officials intervened with the FDA last week and argued that the current data on the effectiveness of the treatment was too weak, the New York Times reported.

CDC: Half of US adults have received one COVID-19 vaccine dose

Data: CDC; Chart: Axios Visuals

Half of US adults have received at least one dose of the COVID-19 vaccine and about a third are fully vaccinated, according to new data from the Centers for Disease Control and Prevention.

Why it matters: COVID-19 cases and hospitalizations are still on the rise, CDC director Rochelle Walensky said during Friday's White House COVID-19 briefing. With cases in many states being driven by variants, public health officials have emphasized the need to ramp up vaccinations.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!